account_balance

Investment manager · 13F filer · SEC CIK 1990717

TRV Gp V, LLC

Reported value$498Mas of Jun 30, 2026
Positions3 0 new, 0 sold out
Top 10 weight100.0%RAPP alone is 53%
FiledAug 1041 days after quarter end

Portfolio · as of Jun 30, 2026

Where the money is

New or addedTrimmedHeld

This fund reports 3 stocks.

Box size is the share of the fund. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.

Show the top 3 as a list
RAPP Rapport Therapeutics, Inc. 52.5% Trimmed −12%SEPN Septerna, Inc. 41.8% HeldMAZE Maze Therapeutics, Inc. 5.7% Held

What changed

Biggest moves since Mar 31, 2026

Filed Aug 10, 2026, compared with the May 7, 2026 filing
add_circleNew

None

arrow_upwardAdded

None

arrow_downwardTrimmed
remove_circleSold out

None

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk.

This is data, not investment advice. About StockToast